Jubilant Pharmova Eyes $150 Million Rupee Debt Sale
Jubilant Pharmova is set to raise funds through a rupee bond offering, primarily for capital expenditure, two merchant bankers said.
By Dharamraj DhutiaIndia's Jubilant Pharmova NSE:JUBLPHARMA is set to raise funds through a rupee bond offering, primarily to invest in capital expenditure, two merchant bankers said on Friday.The company is engaged in specialty pharmaceuticals, contract development and manufacturing, generics, dru…